Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Dopamine in Parkinson's disease
Saad Latif, Muhammad Jahangeer, Dure Maknoon Razia, et al.
Clinica Chimica Acta (2021) Vol. 522, pp. 114-126
Closed Access | Times Cited: 220
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli, Shivakumar Kolachalam, Biancamaria Longoni, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 238-238
Open Access | Times Cited: 157
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials
Hui Wu, Spyridon Siafis, Tasnim Hamza, et al.
Schizophrenia Bulletin (2022) Vol. 48, Iss. 3, pp. 643-654
Open Access | Times Cited: 71
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
Nina Dedic, Heather Dworak, Courtney Zeni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13185-13185
Open Access | Times Cited: 77
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Mark R. Libowitz, Erika L. Nurmi
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 61
Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update
Marianna Rogowska, MARY E. THORNTON, Byron Creese, et al.
Drugs & Aging (2022) Vol. 40, Iss. 1, pp. 21-32
Open Access | Times Cited: 46
Diabetes and Mental Health
David J. Robinson, Kimberley Hanson, Akshay Jain, et al.
Canadian Journal of Diabetes (2023) Vol. 47, Iss. 4, pp. 308-344
Open Access | Times Cited: 35
Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System
Robert A. McCutcheon, Paul J. Harrison, Oliver Howes, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 7, pp. 561-568
Open Access | Times Cited: 26
Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database
Takumi Ebina, Kunihiro Iwamoto, Masahiko Ando, et al.
Psychiatry and Clinical Neurosciences (2025)
Open Access | Times Cited: 1
Challenges of Constipation in People Suffering from Schizophrenia: A Narrative Review
Takahiko Nagamine
Clinics and Practice (2025) Vol. 15, Iss. 2, pp. 33-33
Open Access | Times Cited: 1
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Effect of exposure to endocrine disrupting chemicals in obesity and neurodevelopment: The genetic and microbiota link
Viviana Ramírez, Patricia González-Palacios, Miguel A. Baca, et al.
The Science of The Total Environment (2022) Vol. 852, pp. 158219-158219
Closed Access | Times Cited: 23
Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
Xandra García‐González, Esther Cubo, Lucía Simón-Vicente, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 385-385
Open Access | Times Cited: 14
Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling
D. Kavindi Weerasinghe, Jason M. Hodge, Julie A. Pasco, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Lactate: a prospective target for therapeutic intervention in psychiatric disease
Yanhui Cai, Haiyun Guo, Tianle Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1473-1479
Open Access | Times Cited: 13
Repurposing of nervous system drugs for cancer treatment: recent advances, challenges, and future perspectives
Zixun Wang, Xu Chen, Qi Wang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Assessing a Possibility of Divergent Metabolic Responses to Diet Adjustment and Changes of Eating Behaviours in Female Schizophrenia Patients
M. Friedrich, Joanna Sadowska
Nutrients (2025) Vol. 17, Iss. 7, pp. 1198-1198
Open Access
Non-Beta-Blocker Medications with Beta-Blocker Like Properties: A Systematic Review of Side Effects.
Hany Akeel Al-Hussaniy, Dhuha Salah Noori, Faizul Azam, et al.
Research Journal of Pharmacy and Technology (2025), pp. 599-605
Closed Access
Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia
Myrto Samara, Elisabeth Kottmaier, Bartosz Helfer, et al.
Cochrane library (2025) Vol. 2025, Iss. 4
Closed Access
Delirium Management in the ICU
Michael Reznik, Arjen J. C. Slooter
Current Treatment Options in Neurology (2019) Vol. 21, Iss. 11
Open Access | Times Cited: 35
The Association Between Personality Traits and Dietary Choices: A Systematic Review
Cecilia Maria Esposito, Alessandro Ceresa, Massimiliano Buoli
Advances in Nutrition (2020) Vol. 12, Iss. 4, pp. 1149-1159
Open Access | Times Cited: 33
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Antipsychotic-Induced Alterations in Lipid Turnover
Sandra Pereira, Emily Au, Sri Mahavir Agarwal, et al.
Endocrinology (2023) Vol. 164, Iss. 4
Open Access | Times Cited: 11
Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins
Zeinab Ebrahimian, Bibi Marjan Razavi, Seyed Ali Mousavi Shaegh, et al.
Nutritional Neuroscience (2025), pp. 1-20
Closed Access
Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness
Théo Korchia, Mélanie Faugère, Vincent Achour, et al.
Dialogues in Clinical Neuroscience (2025) Vol. 27, Iss. 1, pp. 10-19
Open Access
Page 1 - Next Page

Scroll to top